{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-008137","form_type":"8-K","ticker":"ETON","cik":"0001710340","company_name":"Eton Pharmaceuticals, Inc.","filed_at":"2025-03-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.535867+00:00","generated_at":"2026-05-24T14:00:18.963977+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Eton Pharma Q4 2024 revenue $11.6M (+59% YoY); net loss narrows to $0.6M","bullets":["Record product revenue of $11.6M in Q4 2024, up 59% from Q4 2023; 16th consecutive quarter of sequential growth.","Net loss improved to $0.6M ($0.02/share) vs $2.3M loss ($0.09/share) in Q4 2023.","Closed transformational acquisition of Increlex (relaunched Jan 2025) and acquired Galzin; both tracking ahead of expectations.","Positive pivotal study for ET-600; NDA submission planned April 2025; ET-400 launch inventory ready with PDUFA May 28.","Cash balance $14.9M at Dec 31, 2024; company expects sequential revenue growth to continue."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-008137","json":"https://secwatch.observer/filing/0001437749-25-008137.json","markdown":"https://secwatch.observer/filing/0001437749-25-008137.md","text":"https://secwatch.observer/filing/0001437749-25-008137.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1710340/000143774925008137/0001437749-25-008137-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1710340/000143774925008137/eton20250305_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T14:00:18.963977+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}